Xel Pharmaceuticals Announces Successful Completion of Prototype ... - MarketWatch
Xel Pharmaceuticals Announces Successful Completion of Prototype ... MarketWatch - ... Inc. announced today the completion of the development of its once-a-week Huperzine A transdermal patch for the treatment of Alzheimer's disease (AD). ... |
Original post: Xel Pharmaceuticals Announces Successful Completion of Prototype ... - MarketWatch by ©2008 Google at alzheimers treatment - Google News
Blog tag: Alzheimers treatment
Technorati tag: Alzheimers treatment